Quality of life with melphalan/prednisone plus either thalidomide (MPT-T) or lenalidomide (MPR-R) in non-transplant eligible newly diagnosed multiple myeloma: results of the HOVON87/NMSG18 study

Claudia A.M. Stege, Lene Kongsgaard Nielsen, Birgit Witte, Bronno van der Holt, Ulf-Henrik Mellqvist, Morten Salomo, Gerard Bos, Mark-David Levin, Heleen Visser-Wisselaar, Markus Hansson, Annette van der Velden, Wendy Deenik, Astrid Gruber, Juleon Coenen, Torben Plesner, Saskia Klein, Bea Tanis, Damian L. Szatkowski, Rolf Brouwer, Matthijs WestermanRineke Leys, Harm Sinnige, Einar Haukås, Klaas van der Hem, Marc Durian, Vera Mattijssen, Vera Mattijssen, Peter Gimsing, Niels van de Donk, Marian Stevens-Kroef, Pieter Sonneveld, Anders Waage, Sonja Zweegman, Niels Abildgaard

Publikation: Bidrag til tidsskriftKonferenceabstrakt i tidsskriftForskningpeer review

OriginalsprogEngelsk
ArtikelnummerS501
TidsskriftHaematologica
Vol/bind102
Udgave nummerS2
Sider (fra-til)190
Antal sider1
ISSN0390-6078
StatusUdgivet - 2017
Begivenhed22nd Congress of the European Hematology Association - Madrid, Spanien
Varighed: 22. jun. 201725. jun. 2017

Konference

Konference22nd Congress of the European Hematology Association
LandSpanien
ByMadrid
Periode22/06/201725/06/2017

Citationsformater